Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% EV-to-FCF is -8.70 as of Jul. 26, 2026. The stock has 5 warning signs investors should review. Among 1,192 Consumer Packaged Goods companies, PURE Bioscience ranks worse than 83892.53% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PURE Bioscience's Enterprise Value is $15.49 Mil.
PURE Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was $-1.78 Mil. Therefore, PURE Bioscience's EV-to-FCF for today is -8.70.
The historical rank and industry rank for PURE Bioscience's EV-to-FCF or its related term are showing as below:
PURE'
s EV-to-FCF Range Over the Past 10 Years
Min: -89.25 Med: -7.36 Max: 249.69
Current: -8.7
During the past 13 years, the highest EV-to-FCF of PURE Bioscience was 249.69. The lowest was -89.25. And the median was -7.36.
PURE's EV-to-FCF is ranked worse than 100% of 1192
companies
in the Consumer Packaged Goods industry
Industry Median: 15.77
vs PURE: -8.70
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PURE Bioscience (OTCPK:PURE) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PURE Bioscience's PE Ratio (TTM) for today is calculated as:
PURE Bioscience's share price for today is $0.07673.
PURE Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PURE Bioscience EV-to-FCF Related Terms
PURE Bioscience EV-to-FCF Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, PURE Bioscience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's EV-to-FCF falls into.
PURE Bioscience's current Enterprise Value is $15.49 Mil.
PURE Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience (PURE) has a EV-to-FCF of -8.70 as of Jul. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PURE Bioscience and its competitors. According to the industry distribution chart, PURE Bioscience ranks #999999 out of 1192 companies in the Consumer Packaged Goods industry.
Is PURE Bioscience's EV-to-FCF too high?
PURE Bioscience's current EV-to-FCF is -8.70. Based on the distribution chart, PURE Bioscience ranks #999999 out of 1192 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PURE Bioscience's EV-to-FCF compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #999999 out of 1192 companies for EV-to-FCF. This places PURE Bioscience in the lower half of its industry. The industry median EV-to-FCF is 15.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.77, based on 1,192 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current EV-to-FCF is -8.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current EV-to-FCF is -8.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PURE Bioscience (PURE), the current EV-to-FCF is -8.70 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
